UnitedHealth Group Inc. (NYSE:UNH) issued an update on its FY16 earnings guidance on Monday morning. The company provided EPS guidance of ~$8.00 for the period, compared to the Thomson Reuters consensus EPS estimate of $8.01. The company issued revenue guidance of exceed $184 billion, compared to the consensus revenue estimate of $184.24 billion.UnitedHealth Group also updated its FY17 guidance to $9.30-9.60 EPS.

Shares of UnitedHealth Group Inc. (NYSE:UNH) traded down 0.46% during trading on Monday, reaching $152.11. 5,022,994 shares of the company traded hands. The firm has a 50 day moving average of $143.37 and a 200 day moving average of $139.61. UnitedHealth Group Inc. has a 52 week low of $107.51 and a 52 week high of $154.50. The stock has a market capitalization of $144.61 billion, a PE ratio of 25.31 and a beta of 0.63.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 18th. The healthcare conglomerate reported $2.17 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.08 by $0.09. UnitedHealth Group had a net margin of 3.62% and a return on equity of 19.92%. The firm earned $46.30 billion during the quarter, compared to analysts’ expectations of $46.09 billion. During the same period last year, the business earned $1.77 earnings per share. UnitedHealth Group’s revenue was up 11.6% compared to the same quarter last year. On average, equities analysts predict that UnitedHealth Group Inc. will post $8.01 EPS for the current year.

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 13th. Investors of record on Friday, December 2nd will be given a dividend of $0.625 per share. This represents a $2.50 annualized dividend and a yield of 1.64%. The ex-dividend date is Wednesday, November 30th. UnitedHealth Group’s payout ratio is currently 36.93%.

Several equities research analysts recently issued reports on UNH shares. Leerink Swann restated an outperform rating on shares of UnitedHealth Group in a research report on Sunday, August 21st. Jefferies Group restated a buy rating on shares of UnitedHealth Group in a research report on Tuesday, August 23rd. Sanford C. Bernstein reiterated an outperform rating and set a $178.00 price target on shares of UnitedHealth Group in a research report on Tuesday, September 6th. Cowen and Company set a $150.00 price target on shares of UnitedHealth Group and gave the company a buy rating in a research report on Tuesday, September 6th. Finally, Evercore ISI began coverage on shares of UnitedHealth Group in a research report on Thursday, September 22nd. They set a buy rating and a $155.00 price target for the company. Two equities research analysts have rated the stock with a hold rating and twenty-two have assigned a buy rating to the company’s stock. The company has a consensus rating of Buy and a consensus target price of $158.03.

In other UnitedHealth Group news, Director Richard T. Burke sold 40,000 shares of the business’s stock in a transaction on Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total value of $5,412,400.00. Following the transaction, the director now directly owns 2,003,550 shares of the company’s stock, valued at approximately $271,100,350.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Gail R. Wilensky sold 5,460 shares of the business’s stock in a transaction on Thursday, November 17th. The shares were sold at an average price of $150.55, for a total transaction of $822,003.00. Following the completion of the transaction, the director now directly owns 60,052 shares in the company, valued at $9,040,828.60. The disclosure for this sale can be found here. 1.65% of the stock is currently owned by insiders.

ILLEGAL ACTIVITY WARNING: This news story was reported by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are reading this news story on another domain, it was illegally stolen and republished in violation of international trademark and copyright law. The original version of this news story can be viewed at https://www.thecerbatgem.com/2016/11/28/unitedhealth-group-inc-unh-issues-fy16-earnings-guidance-2.html.

A number of institutional investors have recently made changes to their positions in UNH. AXA boosted its position in shares of UnitedHealth Group by 4.9% in the second quarter. AXA now owns 1,053,508 shares of the healthcare conglomerate’s stock valued at $148,755,000 after buying an additional 49,280 shares in the last quarter. GAM Holding AG boosted its position in shares of UnitedHealth Group by 24.2% in the second quarter. GAM Holding AG now owns 285,177 shares of the healthcare conglomerate’s stock valued at $40,267,000 after buying an additional 55,524 shares in the last quarter. Atlantic Trust Group LLC boosted its position in shares of UnitedHealth Group by 1.7% in the second quarter. Atlantic Trust Group LLC now owns 1,063,265 shares of the healthcare conglomerate’s stock valued at $150,133,000 after buying an additional 17,444 shares in the last quarter. Van Hulzen Asset Management LLC purchased a new position in shares of UnitedHealth Group during the second quarter valued at about $104,000. Finally, Engineers Gate Manager LP boosted its position in shares of UnitedHealth Group by 634.5% in the second quarter. Engineers Gate Manager LP now owns 21,300 shares of the healthcare conglomerate’s stock valued at $3,008,000 after buying an additional 18,400 shares in the last quarter. 84.92% of the stock is currently owned by institutional investors.

About UnitedHealth Group

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

5 Day Chart for NYSE:UNH

Receive News & Stock Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related stocks with our FREE daily email newsletter.